获得血友病A复发的预后因素来自长期观察性研究的结果
Lisa Reich1, Florian Gatzke1, Steffen Rauchfuss1
1Medical Clinic 2, University Hospital Frankfurt, Germany.
Research and practice in thrombosis and haemostasis
|April 3, 2025
概括
获得性血友病A (AHA) 复发的预测是初始低的第八因子 (FVIII) 活性 (<1 IU/dL) 和未能实现完全缓解. 患有这些因素的患者需要在缓解后至少一年密切监测,因为复发风险更高.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 自免疫性疾病 自免疫性疾病
背景情况:
- 获得性血友病A (AHA) 是一种罕见的自身免疫性疾病,其特征是对凝血因子VIII (FVIII) 的自身抗体.
- AHA可以导致危及生命的出血,虽然已知缓解预测因子,但复发数据有限.
研究的目的:
- 确定获得血友病A.患者中复发的预测因素.
- 分析与AHA患者复发相关的因素,以改善长期管理策略.
主要方法:
- 一项回顾性研究涉及41名AHA患者,分为复发 (n=18) 和稳定缓解 (n=23) 组.
- 用多变量考克斯回归和卡普兰-梅尔分析来评估复发的预测因素,随访时间中位数为3.8年.
主要成果:
- 初始因子VIII (FVIII) 活性低于1IU/dL和未能达到完全缓解 (CR) 是AHA复发的显著预测因素.
- 初始FVIII<1 IU/dL的患者和那些没有达到初始CR的患者的无复发存活率明显较低.
- 抑制剂标位,性别,年龄和初始治疗策略没有显著预测复发.
结论:
- 初始低FVIII活性 (<1 IU/dL) 和初始不完全缓解是AHA复发的关键风险因素.
- 患有这些风险因素的患者在初步缓解后至少一年需要进行警监测,以减轻复发风险.
相关概念视频
Disorders of Hemostasis
664
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
664
Assumptions of Survival Analysis
73
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
73
Extrinsic and Intrinsic Pathways of Hemostasis
4.2K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
4.2K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
570
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
570
X-linked Traits
52.0K
In most mammalian species, females have two X sex chromosomes and males have an X and Y. As a result, mutations on the X chromosome in females may be masked by the presence of a normal allele on the second X. In contrast, a mutation on the X chromosome in males more often causes observable biological defects, as there is no normal X to compensate. Trait variations arising from mutations on the X chromosome are called “X-linked”.
52.0K


